淋巴毒素驱动的癌细胞根除由瘤杀伤性CD8+ TIL
Hongyan Xie1,2,3, Aiping Jiang1,2,3, Aonkon Dey1,2,3,4
1Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
研究人员发现了一种新的CD8+T细胞子集,该子集对瘤根除至关重要. 这些T细胞利用淋巴毒素β受体 (LTβR) 和干扰素 (IFN) 传感途径杀死癌细胞,提供新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤透淋巴细胞 (TIL) 治疗是一种FDA批准的晚期黑色素瘤治疗方法.
- 负责瘤根除的特定TIL亚群尚未完全理解.
- 识别这些关键的TIL子集可以改善治疗策略.
研究的目的:
- 识别和描述涉及癌细胞溶解的新型TIL子集.
- 阐明TIL介导的瘤根除背后的分子机制.
- 为了将TIL子集丰富与对TIL治疗的临床反应相关联.
主要方法:
- 使用患者衍生TIL-黑色素瘤共同培养物.
- 进行了全基因组功能丧失CRISPR查.
- 通过分子测试进行了验证研究.
- 分析了配对的单细胞RNA测序 (scRNA-seq) 和T细胞受体测序 (scTCR-seq) 数据.
主要成果:
- 确定了一种新的CD8+TIL子集,能够进行I类HLA独立的癌细胞溶解.
- 淋巴毒素β受体 (LTβR) 和干扰素 (IFN) 感知通路对于TIL介导的癌细胞杀死至关重要.
- 扩展的CD8+TIL在共同培养时表达高的淋巴毒素β (LTB) 和上调淋巴毒素α (LTA).
- 丰富LTB+ CD8+ T细胞与对TIL治疗的临床反应相关.
- LTB+ CD8+ TIL是从LTBlo CD8+ T细胞中扩展出来的,它们对新抗原有反应.
结论:
- 一种新的CD8+TIL子集,依赖于LTβR和IFN传感,在黑色素瘤瘤根除中起着关键作用.
- 这一子组由新抗原反应性T细胞扩展,其存在与积极的临床结果有关.
- 研究结果提供了对TIL治疗机制和增强抗瘤免疫力的潜在点的见解.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
